子宫内膜异位症的诊断与管理:国际与国家指南的系统综述
该研究检索EMBASE、MEDLINE和PubMed至2016年2月,纳入2部国际和5部国家子宫内膜异位症诊治指南,用AGREE-II评估方法学质量并提取推荐意见。共提取152条不同推荐,仅10条(7%)在指南间可比,42条(28%)无研究证据支持,欧洲人类生殖与胚胎学学会指南方法学质量最高(88/100)。
要点
- 共纳入2部国际和5部国家指南,提取152条推荐,仅10条(7%)在指南间可比。
- 42条推荐(28%)无研究证据支持,可比推荐的支持证据差异大。
- 欧洲人类生殖与胚胎学学会指南方法学质量最高,评分88/100。
核心结论
- 子宫内膜异位症指南的推荐意见和方法学质量存在显著差异。
- 未来指南应参考高质量方法并与关键利益相关者(包括子宫内膜异位症女性)协商制定,确保其范围能真正指导临床实践并消除不必要且不合理的临床实践差异。
研究设计与样本
- 系统综述,检索EMBASE、MEDLINE和PubMed从建库至2016年2月,纳入子宫内膜异位症诊断与管理相关指南,共纳入2部国际和5部国家指南。
- 由4名独立作者使用AGREE-II工具评估方法学质量,并系统提取指南推荐意见及支持研究证据。
主要发现
- 共提取152条不同推荐,其中10条(7%)在指南间可比。
- 42条推荐(28%)无研究证据支持。
- 各指南对可比推荐所呈现的支持证据存在显著差异。
- 欧洲人类生殖与胚胎学学会指南被客观评估为最高质量指南,方法学质量评分88/100。
- 无指南遵循AGREE-II标准化指南制定方法。
关键数值与推荐
- 共纳入2部国际和5部国家指南,提取152条推荐,10条(7%)可比,42条(28%)无研究证据支持。
- 欧洲人类生殖与胚胎学学会指南方法学质量评分88/100。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The development of clinical guidelines requires standardised methods informed by robust evidence synthesis. OBJECTIVES: We evaluated the methodological quality of endometriosis guidelines, mapped their recommendations, and explored the relationships between recommendations and research evidence. SEARCH STRATEGY: We searched EMBASE, MEDLINE, and PubMed from inception to February 2016. SELECTION CRITERIA: We included guidelines related to the diagnosis and management of endometriosis. DATA COLLECTION AND ANALYSIS: The search strategy identified 879 titles and abstracts. We include two international and five national guidelines. Four independent authors assessed the methodological quality of the included guidelines, using the Appraisal of Guidelines for Research & Evaluation (AGREE-II) instrument, and systematically extracted the guideline recommendations and supporting research evidence. MAIN RESULTS: One hundred and fifty-two different recommendations were made. Ten recommendations (7%) were comparable across guidelines. The European Society of Human Reproduction and Embryology was objectively evaluated as the highest quality guideline (methodological quality score: 88/100). There was substantial variation between the supporting evidence presented by individual guidelines for comparable recommendations. Forty-two recommendations (28%) were not supported by research evidence. No guideline followed the standardised guideline development methods (AGREE-II). CONCLUSIONS: There is substantial variation in the recommendations and methodological quality of endometriosis guidelines. Future guidelines should be developed with reference to high-quality methods in consultation with key stakeholders, including women with endometriosis, ensuring that their scope can truly inform clinical practice and eliminate unwarranted and unjustified variations in clinical practice. TWEETABLE ABSTRACT: #Endometriosis guidelines vary in recommendations and quality. @EndometriosisUK.
引用
- Hirsch M, Begum MR, Paniz É, et al. Diagnosis and management of endometriosis: a systematic review of international and national guidelines. BJOG. 2017. PMID: 28755422. doi:10.1111/1471-0528.14838
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。